UK markets closed

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.92-1.12 (-6.98%)
At close: 04:00PM EDT
14.92 0.00 (0.00%)
After hours: 07:32PM EDT

Immunome, Inc.

18702 N. Creek Parkway
Suite 100
Bothell, WA 98011
United States
610-321-3700
https://immunome.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees62

Key executives

NameTitlePayExercisedYear born
Dr. Clay B. Siegall Ph.D.President, CEO & Chairman1.43MN/A1961
Dr. Jack Higgins Ph.D.Chief Scientific Officer956.34kN/A1980
Dr. Robert J. Lechleider M.D.Chief Medical Officer512.49kN/A1961
Mr. Max RosettExecutive VP of Operations, Principal Accounting & Financial Officer and CFON/AN/A1990
Ms. Sandra G. Stoneman Esq., J.D.Chief Legal Officer, General Counsel & Corporate Secretary443.43kN/A1974
Mr. Bruce Turner M.D., Ph.D.Chief Strategy OfficerN/AN/A1964
Mr. Kinney HornChief Business OfficerN/AN/A1975
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Corporate governance

Immunome, Inc.’s ISS governance QualityScore as of 1 June 2024 is 10. The pillar scores are Audit: 7; Board: 8; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.